Liquid Biopsy
News and reporting on cell-free DNA testing.
Gene Solutions, NEWCL Establish NGS Lab in Taiwan
The companies aim to jointly commercialize Gene Solutions' suite of prenatal and cancer tests throughout Taiwan.
MiRxes Launches HK$880.5M IPO on Hong Kong Stock Exchange
The Singaporean company said it will use the proceeds to support commercialization of its gastric cancer test, further assay development, and other business purposes.
Grail Q1 Revenues up 19 Percent Driven by Clinical Test Growth
Grail shared new results from the NHS trial of its Galleri screening test, which brought in $29.1 million in Q1, a 24 percent increase over the same quarter last year.
Grail, Athenahealth Ink Deal to Facilitate Liquid Biopsy Test Ordering
The integration will enable more than 160,000 US clinicians on the Athenahealth network to "opt in to more seamlessly order Galleri directly in the EHR," Grail said in a statement.
New Grail Publication Explores Optimal Liquid Biopsy MCED Test Interval for Mortality Impact
Premium
Company investigators calculated the expected reduction in late-stage cancer diagnoses and projected drops in mortality for different screening schedules in different models of cancer growth.